-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 LJTWuy3bI09LGpCPzLoEukaWVt7mSXVP1rU8NV5OgIqd+7aG6puOOi9bRUz1fsvx
 l15wsv0EyjVtFvAXngAc5w==

<SEC-DOCUMENT>0001000096-05-000103.txt : 20050215
<SEC-HEADER>0001000096-05-000103.hdr.sgml : 20050215
<ACCEPTANCE-DATETIME>20050215151720
ACCESSION NUMBER:		0001000096-05-000103
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20050209
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20050215
DATE AS OF CHANGE:		20050215

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			INTEGRATED SURGICAL SYSTEMS INC
		CENTRAL INDEX KEY:			0000894871
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				680232575
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-12471
		FILM NUMBER:		05616785

	BUSINESS ADDRESS:	
		STREET 1:		1850 RESEARCH PARK DR
		CITY:			DAVIS
		STATE:			CA
		ZIP:			95616-4884
		BUSINESS PHONE:		5307922600

	MAIL ADDRESS:	
		STREET 1:		1850 RESEARCH PARK
		CITY:			DAVIS
		STATE:			CA
		ZIP:			95616-4884
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>integrated8k.txt
<DESCRIPTION>FORM 8-K
<TEXT>


                UNITED STATES SECURITIES AND EXCHANGE COMMISSION
                              Washington, DC 20549

                                    FORM 8-K

                                 CURRENT REPORT

     Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934

       Date of report (Date of earliest event reported): February 9, 2005

                        Integrated Surgical Systems, Inc.
                        ---------------------------------
               (Exact name of registrant as specified in charter)

     Delaware                           1-12471               68-0232575
     --------                           -------               ----------
(State or other jurisdiction           (Commission            (IRS Employer
     of incorporation)                  File Number)        Iden tification No.)


     1850 Research Park Drive
          Davis, California                                      95616-4884
          -----------------                                      ----------
(Address of principal executive offices)                         (Zip Code)

Registrant's telephone number, including area code:  (530) 792-2600

                                 Not Applicable
                                 --------------
          (Former name or former address, if changed since last report)

     Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions: G Written communications pursuant to Rule 425 under the
Securities Act (17 CFR 230.425) G Soliciting material pursuant to Rule 14a-12
under the Exchange Act (17 CFR 240.14a-12) G Pre-commencement communications
pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) G
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act
(17 CFR 240.13e-4(c))

<PAGE>


Item 8. Other Events.

On February 9, 2005, we, Integrated Surgical Systems, Inc., reached an agreement
with the holder of our 6-3/4% Convertible Debenture which we issued on June 9,
2004. This agreement provides that (a) the "conversion price" set forth in
section 3.1(a) of the debenture be amended to be the lesser of: (i) $0.025 or
(ii) 75% of the average of the five lowest volume weighted average prices during
the twenty days prior to the holder's election to convert the amount outstanding
under the debenture; and (b) the date by which we are required to cause a
registration statement to be declared effective by the Securities and Exchange
Commission, with respect to the shares issuable upon conversion of the debenture
and exercise of the warrants issued together with the debenture, be extended to
April 30, 2005.

The conversion price originally was set at the lesser of: (i) $0.025 or (ii) 80%
of the average of the five lowest volume weighted average prices during the
twenty days prior to the holder's election to convert the amount outstanding
under the debenture. Further, the original terms of the debenture and warrants
required that the registration statement for the underlying shares be declared
effective by the SEC by November 6, 2004.

The debenture was attached as exhibit 10.1 to our Quarterly Report on Form
10-QSB for the quarter ended June 30, 2004, filed with the SEC on November 24,
2004. The warrant certificate evidencing the warrants was attached as exhibit
10.2 to such Form 10-QSB.


Item 9.01. Financial Statements and Exhibits.

Set forth below are all exhibits applicable to this Current Report on Form 8-K.

Exhibit
Number        Description
- ------        -----------


10.1     Addendum to Convertible Debenture and Warrant to Purchase Common Stock,
         dated February 9, 2005, between Integrated Surgical Systems, Inc.
         and Golden Gate Investors, Inc.



<PAGE>


                                   SIGNATURES


Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.


                                    Integrated Surgical Systems, Inc.

Dated: February 15, 2005            By: /s/ RAMISH TRIVEDI
                                        ----------------------------------------
                                        Ramesh Trivedi, Chief Executive Officer

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>goldengateexhibit.txt
<DESCRIPTION>ADDENDUM
<TEXT>

                                                                    Exhibit 10.1


                      ADDENDUM TO CONVERTIBLE DEBENTURE AND
                        WARRANT TO PURCHASE COMMON STOCK

This addendum to Convertible Debenture and Warrant to Purchase Common Stock
("Addendum") is entered into as of the 9th day of February 2005 by and between
Integrated Surgical Systems, Inc., a Delaware corporation ("Integrated"), and
Golden Gate Investors, Inc., a California corporation ("GGI").

WHEREAS, GGI and Integrated are parties to that certain 6 3/4% Convertible
Debenture dated as of June 9, 2004 ("Debenture"); and

WHEREAS, GGI and Integrated are parties to that certain Warrant to Purchase
Common Stock dated June 9, 2004 ("Warrant"); and

WHEREAS, the parties desire to amend the Debenture and Warrant in certain
respects.

NOW, THEREFORE, in consideration of the mutual promises and covenants contained
herein, and for other good and valuable consideration, the receipt and
sufficiency of which are hereby acknowledged, Integrated and GGI agree as
follows:

     1.   All terms used herein and not otherwise defined herein shall have the
          definitions set forth in the debenture.

     2.   The Deadline is hereby changed to be April 30, 2005.

     3.   The Conversion Price set forth in section 3.1(a) of the Debenture is
          hereby changed to be the lesser of: (i) $0.25, or (ii) seventy-five
          percent (75%) of the average of the five lowest Volume Weighted
          Average Prices during the 20 Trading Days prior to GGI's election to
          convert (a "Discount Multiplier").

     4.   Except as specifically amended herein, all other terms and conditions
          of the Debenture and Warrant shall remain in full force and effect.

IN WITNESS WHEREOF, Integrated and GGI have caused this Addendum to be signed by
its duly authorized officers on the date first set forth above.


Integrated Surgical Systems, Inc.           Golden Gate Investors, Inc.
/s/  RAMESH  TRIVEDI                        /s/  TRAVIS HUFF
- ---------------------------------           ------------------------------------
Ramesh Trivedi                              Travis Huff
President/CEO                               Portfolio Manager
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
